| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |